Latvian pharmaceutical company Olpha has achieved a significant milestone with the topping-out of its new manufacturing facility for finished dosage forms. This marks a major step forward in expanding the company’s production capabilities and solidifying its position in the pharmaceutical industry. The new facility will enable Olpha to meet growing demand for its products and increase its export potential. Construction began recently, and the "topping-out" ceremony signifies the completion of the building's structural framework. The company anticipates the plant will create numerous jobs in the region. This investment highlights Latvia’s growing attractiveness as a destination for pharmaceutical manufacturing and foreign investment, with the facility anticipated to be fully operational in the near future.